Ionis Reports Substantial Drop In Acute Pancreatitis Events With Cholesterol Lowering Drug
1. Olezarsen reduces fasting triglyceride levels by up to 72%. 2. 85% reduction in acute pancreatitis events observed with olezarsen. 3. 86% of patients achieved triglyceride levels below 500 mg/dL. 4. IONS plans to submit supplemental FDA application by year-end. 5. Shares retreated 5.21% at publication time.